Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
INXB —
INHIBRX BIOSCIENCES INC
CUSIP: 45720N103 · Held by 3 superinvestors · Combined value: $134,173,995
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Andreas Halvorsen | 0.3% | $113,578,695 | 1,437,705 | REDUCE | -350,000 |
| 2 | Ken Griffin | 0.0% | $16,439,900 | 208,100 | ADD | +150,906 |
| 3 | Jim Simons | 0.0% | $4,155,400 | 52,600 | ADD | +44,200 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +44,200 | +526.2% |
| Ken Griffin | ADD | +150,906 | +263.8% |
| Andreas Halvorsen | REDUCE | -350,000 | -19.6% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | NEW BUY | +8,400 | New |
| Ken Griffin | NEW BUY | +57,194 | New |
Who Owns INXB? Superinvestor Holdings
INHIBRX BIOSCIENCES INC is held by 3 tracked superinvestors, with a combined position value of $134 million . The largest positions are held by Andreas Halvorsen (0.3% of portfolio), Ken Griffin (0.0% of portfolio), Jim Simons (0.0% of portfolio).
In the most recent quarter, 2 superinvestors added or initiated positions while 1 reduced or exited.